|
|
Volumn 31, Issue 4, 2003, Pages 776-
|
|
Consensus statement on the future of mannan-binding lectin (MBL)-replacement therapy
|
|
Author keywords
Collectin; Innate immunity; Mannan binding lectin (MBL); MBL therapy
|
|
Indexed keywords
MANNAN BINDING LECTIN;
RECOMBINANT PROTEIN;
BIRTH RATE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CYSTIC FIBROSIS;
DISEASE ASSOCIATION;
DISEASE PREDISPOSITION;
DRUG EFFICACY;
HUMAN;
HUMAN IMMUNODEFICIENCY VIRUS INFECTION;
LUNG FUNCTION;
MANNAN BINDING LECTIN DEFICIENCY;
PRIORITY JOURNAL;
PROGNOSIS;
PROSPECTIVE STUDY;
PROTEIN DEFICIENCY;
RANDOMIZED CONTROLLED TRIAL;
RHEUMATOID ARTHRITIS;
SPONTANEOUS ABORTION;
CONTROLLED CLINICAL TRIALS;
HUMANS;
MANNOSE-BINDING LECTIN;
THERAPEUTICS;
HUMAN IMMUNODEFICIENCY VIRUS;
|
|
EID: 0043069690
PISSN: 03005127
EISSN: None
Source Type: Journal
DOI: 10.1042/BST0310776 Document Type: Conference Paper |
|
Times cited : (9)
|
|
References (0)
|
